MediWound (MDWD) Cash from Investing Activities (2013 - 2025)
MediWound (MDWD) recorded quarterly Cash from Investing Activities of -$23.9 million in Q4 2025, down 645.58% quarter-over-quarter from $4.4 million in Q3 2025, and down 594.84% on a YoY basis from $4.8 million in Q4 2024.
MediWound (MDWD) Cash from Investing Activities (2013 - 2025) Analysis & Trends
MediWound's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$23.9 million for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 594.84% year-over-year to -$23.9 million; the TTM figure through Dec 2025 stood at -$18.0 million (down 113.77% YoY), while the FY2025 annual figure was -$18.0 million, down 113.77% from the prior year.
- Cash from Investing Activities was -$23.9 million for Q4 2025 at MediWound, down from $4.4 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $5.0 million in Q4 2023 to a low of -$26.1 million in Q2 2023.
- Historically, Cash from Investing Activities has averaged -$2.9 million across 5 years, with a median of -$122500.0 in 2021.
- Biggest YoY gain for Cash from Investing Activities was 2165.52% in 2022; the steepest drop was 8690.0% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$116000.0 in 2021, then surged by 2165.52% to $2.4 million in 2022, then surged by 109.85% to $5.0 million in 2023, then fell by 3.98% to $4.8 million in 2024, then tumbled by 594.84% to -$23.9 million in 2025.
- The last three Cash from Investing Activities figures came in at -$23.9 million (Q4 2025), $4.4 million (Q3 2025), and $4.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 579,519.10 |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -23.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.89 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Jun 30, 2025 | 4.91 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Sep 30, 2024 | -14.29 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 2.85 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Mar 31, 2024 | -1.78 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Dec 31, 2023 | 5.03 Mn |
| Sep 30, 2023 | -5.83 Mn |
| Sep 30, 2023 | -5.83 Mn |